2527: The International Registry on Hand and Composite Tissue Allotransplantation (IRHCTT)
P. Petruzzo, J. Dubernard, M. Lanzetta
{"title":"2527: The International Registry on Hand and Composite Tissue Allotransplantation (IRHCTT)","authors":"P. Petruzzo, J. Dubernard, M. Lanzetta","doi":"10.1080/23723505.2016.1232944","DOIUrl":null,"url":null,"abstract":"2527: The International Registry on Hand and Composite Tissue Allotransplantation (IRHCTT) Palmina Petruzzo, MD, Jean Michel Dubernard, and Marco Lanzetta, MD Hopital Edouard Herriot, Lyon, France; Italian Institute of Hand Surgery, Monza, Italy Background The primary purpose of the IRHCTT is to collect information on voluntary basis. At present it includes upper extremity (UET) and face allotransplantations (FT). Methods 25 unilateral and 31 bilateral UET, for a total of 56 patients have been reported. In the majority of cases the level of amputation was distal, but there were also 9 arm transplantations. Twenty-eight cases of partial or total face allotransplantations have been reported. In the majority of cases the deficit included cheek, nose, chin, lips and perioral area. In both types of transplantation the immunosuppressive therapy included tacrolimus, mycophenolate mofetil, sirolimus and steroids; polyclonal or monoclonal antibodies were used for induction. Results Patient survival in UET was 9637%: 1 patient died after simultaneous face and bilateral hand transplantation and another one after bilateral arm transplantation; while in FT it was 8572% (4 patients died including the case of simultaneous face and bilateral hand transplantation) Graft survival in UET was 8182%: in 5 cases it occurred in the first period after transplantation (poor vascularization or infectious complications) and in other 5 during the follow-up (chronic rejection/graft vasculopathy) Graft survival in FT was 9643% (one face graft was removed for unknown cause). In UET 74% of the recipients experienced at least one episode of acute rejection within the first posttransplant year and 60% in FT Six cases of chronic rejection in UET and one in FT have been reported Complications included, as in solid organ transplantation, opportunistic infections, metabolic complications and malignancies. Hand-grafted patients developed protective sensibility, 90% of them tactile sensibility and 823% developed also a partial discriminative sensibility Motor recovery enabling patients to perform most daily activities Face-grafted patients improved their aesthetic aspect and they were able to perform some activities such as eating, drinking and speaking which were impossible before the transplantation. Conclusions UET and FT are successful procedures, however careful evaluation of patients before and after transplantation are indispensable. CONTACT Palmina Petruzzo, MD petruzzo@medicina.unica.it © 2016 Palmina Petruzzo, Jean Michel Dubernard, and Marco Lanzetta. Published with license by Taylor & Francis. This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted. VASCULARIZED COMPOSITE ALLOTRANSPLANTATION 2016, VOL. 3, NOS. 1–2, 7 http://dx.doi.org/10.1080/23723505.2016.1232944","PeriodicalId":372758,"journal":{"name":"Vascularized Composite Allotransplantation","volume":"52 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2016-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vascularized Composite Allotransplantation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/23723505.2016.1232944","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4
Abstract
2527: The International Registry on Hand and Composite Tissue Allotransplantation (IRHCTT) Palmina Petruzzo, MD, Jean Michel Dubernard, and Marco Lanzetta, MD Hopital Edouard Herriot, Lyon, France; Italian Institute of Hand Surgery, Monza, Italy Background The primary purpose of the IRHCTT is to collect information on voluntary basis. At present it includes upper extremity (UET) and face allotransplantations (FT). Methods 25 unilateral and 31 bilateral UET, for a total of 56 patients have been reported. In the majority of cases the level of amputation was distal, but there were also 9 arm transplantations. Twenty-eight cases of partial or total face allotransplantations have been reported. In the majority of cases the deficit included cheek, nose, chin, lips and perioral area. In both types of transplantation the immunosuppressive therapy included tacrolimus, mycophenolate mofetil, sirolimus and steroids; polyclonal or monoclonal antibodies were used for induction. Results Patient survival in UET was 9637%: 1 patient died after simultaneous face and bilateral hand transplantation and another one after bilateral arm transplantation; while in FT it was 8572% (4 patients died including the case of simultaneous face and bilateral hand transplantation) Graft survival in UET was 8182%: in 5 cases it occurred in the first period after transplantation (poor vascularization or infectious complications) and in other 5 during the follow-up (chronic rejection/graft vasculopathy) Graft survival in FT was 9643% (one face graft was removed for unknown cause). In UET 74% of the recipients experienced at least one episode of acute rejection within the first posttransplant year and 60% in FT Six cases of chronic rejection in UET and one in FT have been reported Complications included, as in solid organ transplantation, opportunistic infections, metabolic complications and malignancies. Hand-grafted patients developed protective sensibility, 90% of them tactile sensibility and 823% developed also a partial discriminative sensibility Motor recovery enabling patients to perform most daily activities Face-grafted patients improved their aesthetic aspect and they were able to perform some activities such as eating, drinking and speaking which were impossible before the transplantation. Conclusions UET and FT are successful procedures, however careful evaluation of patients before and after transplantation are indispensable. CONTACT Palmina Petruzzo, MD petruzzo@medicina.unica.it © 2016 Palmina Petruzzo, Jean Michel Dubernard, and Marco Lanzetta. Published with license by Taylor & Francis. This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted. VASCULARIZED COMPOSITE ALLOTRANSPLANTATION 2016, VOL. 3, NOS. 1–2, 7 http://dx.doi.org/10.1080/23723505.2016.1232944
2527:国际手部和复合组织同种异体移植注册(IRHCTT)
2527:国际手部和复合组织同种异体移植注册(IRHCTT) Palmina Petruzzo, MD, Jean Michel Dubernard和Marco Lanzetta, MD医院,里昂,法国;背景IRHCTT的主要目的是在自愿的基础上收集信息。目前包括上肢移植(UET)和面部移植(FT)。方法对56例患者进行单侧UET 25例,双侧UET 31例。大多数病例截肢水平在远端,但也有9例手臂移植。报告了28例面部部分或全部异体移植。在大多数情况下,缺陷包括脸颊,鼻子,下巴,嘴唇和口周区域。在两种类型的移植中,免疫抑制治疗包括他克莫司、霉酚酸酯、西罗莫司和类固醇;采用多克隆或单克隆抗体诱导。结果UET患者生存率为9637%,其中面部及双侧手同时移植死亡1例,双侧手臂同时移植死亡1例;而FT组为8572%(4例患者死亡,包括同时进行面部和双侧手移植),UET组的移植物存活率为8182%,其中5例发生在移植后的第一阶段(血管化不良或感染并发症),另外5例发生在随访期间(慢性排斥反应/移植物血管病变),FT组的移植物存活率为9643%(1例面部移植物因不明原因切除)。在UET中,74%的受者在移植后的第一年内至少经历一次急性排斥反应,而在FT中,这一比例为60%。据报道,UET中有6例慢性排斥反应,FT中有1例,并发症包括实体器官移植、机会性感染、代谢并发症和恶性肿瘤。手部移植的患者有了保护感,90%的人有了触觉感823%的人也有了部分的辨别感运动恢复使患者能够进行大部分的日常活动面部移植的患者改善了他们的审美方面他们能够进行一些活动如吃饭,喝水和说话这些在移植前是不可能的。结论UET和FT是成功的手术,但移植前后患者的仔细评估是必不可少的。Palmina Petruzzo, MD petruzzo@medicina.unica.it©2016 Palmina Petruzzo, Jean Michel Dubernard和Marco Lanzetta。由Taylor & Francis授权出版。这是一篇在知识共享署名-非商业许可(http://creativecommons.org/licenses/by-nc/3.0/)条款下发布的开放获取文章,该许可允许在任何媒体上不受限制的非商业使用、分发和复制,前提是正确引用原始作品。指定作者的精神权利得到了维护。血管化复合异体移植,2016,VOL. 3, no .1 - 2,7 http://dx.doi.org/10.1080/23723505.2016.1232944
本文章由计算机程序翻译,如有差异,请以英文原文为准。